The DOI matches its Crossref record; 304 of the 304 references it cites were found in a registry or an index.
Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology
Open accessAbstract
Targeted covalent inhibitors (TCIs) are designed to bind poorly conserved amino acids by means of reactive groups, the so-called warheads. Currently, targeting noncatalytic cysteine residues with acrylamides and other α,β-unsaturated carbonyl compounds is the predominant strategy in TCI development. The recent ascent of covalent drugs has stimulated considerable efforts to characterize alternative warheads for the covalent-reversible and irreversible engagement of noncatalytic cysteine residues as well as other amino acids. This Perspective article provides an overview of warheads-beyond α,β-unsaturated amides-recently used in the design of targeted covalent ligands. Promising reactive groups that have not yet demonstrated their utility in TCI development are also highlighted. Special emphasis is placed on the discussion of reactivity and of case studies illustrating applications in medicinal chemistry and chemical biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pearson, R. G. (1963) · Journal of the American Chemical Society · doi:10.1021/ja00905a001 · Cited by 10,475
DrugBank 5.0: a major update to the DrugBank database for 2018
Wishart, D. S., Feunang, Y. D., Guo, A. C., Lo, E. J., Marcu, A., Grant, J. R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1037 · Cited by 8,404
Applications of Fluorine in Medicinal Chemistry
Gillis, E. P., Eastman, K. J., Hill, M. D., Donnelly, D. J., & Meanwell, N. A. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00258 · Cited by 3,618
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566
The molecular hallmarks of epigenetic control
Allis, C. D., & Jenuwein, T. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.59 · Cited by 2,809
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
Meanwell, N. A. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01788 · Cited by 2,655
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
Ostrem, J. M., Peters, U., Sos, M. L., Wells, J. A., & Shokat, K. M. (2013) · Nature · doi:10.1038/nature12796 · Cited by 2,557
Proteomic analysis of post-translational modifications
Mann, M., & Jensen, O. N. (2003) · Nature Biotechnology · doi:10.1038/nbt0303-255 · Cited by 2,134
The resurgence of covalent drugs
Singh, J., Petter, R. C., Baillie, T. A., & Whitty, A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3410 · Cited by 1,873
The free amino groups of insulin
Sanger, F. (1945) · Biochemical Journal · doi:10.1042/bj0390507 · Cited by 1,825
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
Fleming, F. F., Yao, L., Ravikumar, P. C., Funk, L., & Shook, B. C. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100762r · Cited by 1,754
Quantitative reactivity profiling predicts functional cysteines in proteomes
Weerapana, E., Wang, C., Simon, G. M., Richter, F., Khare, S., Dillon, M. B. D., Bachovchin, D. A., Mowen, K., Baker, D., & Cravatt, B. F. (2010) · Nature · doi:10.1038/nature09472 · Cited by 1,684
Esters of Methanesulfonic Acid as Irreversible Inhibitors of Acetylcholinesterase
Kitz, R., & Wilson, I. B. (1962) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50153-8 · Cited by 1,519
The cellular thermal shift assay for evaluating drug target interactions in cells
Jafari, R., Almqvist, H., Axelsson, H., Ignatushchenko, M., Lundbäck, T., Nordlund, P., & Molina, D. M. (2014) · Nature Protocols · doi:10.1038/nprot.2014.138 · Cited by 1,474
Sulfur(VI) Fluoride Exchange (SuFEx): Another Good Reaction for Click Chemistry
Dong, J., Krasnova, L., Finn, M. G., & Sharpless, K. B. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201309399 · Cited by 1,390
Activity-Based Protein Profiling: From Enzyme Chemistry to Proteomic Chemistry
Cravatt, B. F., Wright, A. T., & Kozarich, J. W. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.101304.124125 · Cited by 1,270
Walker, E. H., Pacold, M. E., Perisic, O., Stephens, L., Hawkins, P. T., Wymann, M. P., & Williams, R. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00089-4 · Cited by 1,197
Advances in Chemical Protein Modification
Boutureira, O., & Bernardes, G. J. L. (2015) · Chemical Reviews · doi:10.1021/cr500399p · Cited by 1,132
Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
Powers, J. C., Asgian, J. L., Ekici, Ö. D., & James, K. E. (2002) · Chemical Reviews · doi:10.1021/cr010182v · Cited by 1,090
Kinase inhibitors: the road ahead
Ferguson, F. M., & Gray, N. S. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.21 · Cited by 1,009
Proteome-wide covalent ligand discovery in native biological systems
Backus, K. M., Correia, B. E., Lum, K. M., Forli, S., Horning, B. D., González-Páez, G. E., Chatterjee, S., Lanning, B. R., Teijaro, J. R., Olson, A. J., et al. (2016) · Nature · doi:10.1038/nature18002 · Cited by 940
Functional and quantitative proteomics using SILAC
Mann, M. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2067 · Cited by 931
TRP channel activation by reversible covalent modification
Hinman, A., Chuang, H.-H., Bautista, D. M., & Julius, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609598103 · Cited by 890
Ruthenium-Catalyzed Azide−Alkyne Cycloaddition: Scope and Mechanism
Boren, B. C., Narayan, S., Rasmussen, L. K., Zhang, L., Zhao, H., Lin, Z., Jia, G., & Fokin, V. V. (2008) · Journal of the American Chemical Society · doi:10.1021/ja0749993 · Cited by 829
Structure and function of an irreversible agonist-β2 adrenoceptor complex
Rosenbaum, D. M., Zhang, C., Lyons, J. A., Holl, R., Aragao, D., Arlow, D. H., Rasmussen, S. G. F., Choi, H.-J., DeVree, B. T., Sunahara, R. K., et al. (2011) · Nature · doi:10.1038/nature09665 · Cited by 767
Cysteine Proteases and Their Inhibitors
Otto, H.-H., & Schirmeister, T. (1997) · Chemical Reviews · doi:10.1021/cr950025u · Cited by 759
Wymann, M. P., Bulgarelli-Leva, G., Zvelebil, M. J., Pirola, L., Vanhaesebroeck, B., Waterfield, M. D., & Panayotou, G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1722 · Cited by 682
Discovery of Selective Irreversible Inhibitors for Bruton’s Tyrosine Kinase
Pan, Z., Scheerens, H., Li, S., Schultz, B. E., Sprengeler, P. A., Burrill, L. C., Mendonca, R. V., Sweeney, M. D., Scott, K. C. K., Grothaus, P. G., et al. (2007) · ChemMedChem · doi:10.1002/cmdc.200600221 · Cited by 674
Franken, H., Mathieson, T., Childs, D., Sweetman, G. M. A., Werner, T., Tögel, I., Doce, C., Gade, S., Bantscheff, M., Drewes, G., et al. (2015) · Nature Protocols · doi:10.1038/nprot.2015.101 · Cited by 659
Development of the Proteasome Inhibitor Velcade™ (Bortezomib)
Adams, J., & Kauffman, M. (2004) · Cancer Investigation · doi:10.1081/cnv-120030218 · Cited by 654
Developing Irreversible Inhibitors of the Protein Kinase Cysteinome
Liu, Q., Sabnis, Y., Zhao, Z., Zhang, T., Buhrlage, S. J., Jones, L. H., & Gray, N. S. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.12.006 · Cited by 652
CH5424802, a Selective ALK Inhibitor Capable of Blocking the Resistant Gatekeeper Mutant
Sakamoto, H., Tsukaguchi, T., Hiroshima, S., Kodama, T., Kobayashi, T., Fukami, T. A., Oikawa, N., Tsukuda, T., Ishii, N., & Aoki, Y. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.04.004 · Cited by 636
Augeri, D. J., Robl, J. A., Betebenner, D. A., Magnin, D. R., Khanna, A., Robertson, J. G., Wang, A., Simpkins, L. M., Taunk, P., Huang, Q., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050261p · Cited by 624
Falagas, M. E., Vouloumanou, E. K., Samonis, G., & Vardakas, K. Z. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00068-15 · Cited by 612
Native Mass Spectrometry: What is in the Name?
Leney, A. C., & Heck, A. J. R. (2017) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-016-1545-3 · Cited by 602
Copper-catalysed azide–alkyne cycloadditions (CuAAC): an update
Haldón, E., Nicasio, M. C., & Pérez, P. J. (2015) · Organic & Biomolecular Chemistry · doi:10.1039/c5ob01457c · Cited by 598
Cross, B. C. S., Bond, P. J., Sadowski, P. G., Jha, B. K., Zak, J., Goodman, J. M., Silverman, R. H., Neubert, T. A., Baxendale, I. R., Ron, D., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115623109 · Cited by 591
Jackson, P. A., Widen, J. C., Harki, D. A., & Brummond, K. M. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00788 · Cited by 588
Epoxide electrophiles as activity-dependent cysteine protease profiling and discovery tools
Greenbaum, D., Medzihradszky, K. F., Burlingame, A., & Bogyo, M. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00014-4 · Cited by 581
Targeted Covalent Inhibitors for Drug Design
Baillie, T. A. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201601091 · Cited by 578
Residue-Specific Peptide Modification: A Chemist’s Guide
deGruyter, J. N., Malins, L. R., & Baran, P. S. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b00536 · Cited by 573
Leesnitzer, L. M., Parks, D. J., Bledsoe, R. K., Cobb, J. E., Collins, J. L., Consler, T. G., Davis, R. G., Hull-Ryde, E. A., Lenhard, J. M., Patel, L., et al. (2002) · Biochemistry · doi:10.1021/bi0159581 · Cited by 566
Sulfonyl fluorides as privileged warheads in chemical biology
Narayanan, A., & Jones, L. H. (2015) · Chemical Science · doi:10.1039/c5sc00408j · Cited by 546
Structural Basis of Perturbed pKa Values of Catalytic Groups in Enzyme Active Sites
Harris, T. K., & Turner, G. J. (2002) · IUBMB Life · doi:10.1080/15216540211468 · Cited by 535
Bauer, R. A. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.05.005 · Cited by 534
A summary of the measured p K values of the ionizable groups in folded proteins
Grimsley, G. R., Scholtz, J. M., & Pace, C. N. (2009) · Protein Science · doi:10.1002/pro.19 · Cited by 528
Redox-based reagents for chemoselective methionine bioconjugation
Lin, S., Yang, X., Jia, S., Weeks, A. M., Hornsby, M., Lee, P. S., Nichiporuk, R. V., Iavarone, A. T., Wells, J. A., Toste, F. D., et al. (2017) · Science · doi:10.1126/science.aal3316 · Cited by 513
Structural Bioinformatics-Based Design of Selective, Irreversible Kinase Inhibitors
Cohen, M. S., Zhang, C., Shokat, K. M., & Taunton, J. (2005) · Science · doi:10.1126/science1108367 · Cited by 506
Molecular Mechanisms of Aldehyde Toxicity: A Chemical Perspective
LoPachin, R. M., & Gavin, T. (2014) · Chemical Research in Toxicology · doi:10.1021/tx5001046 · Cited by 495
Reversible targeting of noncatalytic cysteines with chemically tuned electrophiles
Serafimova, I. M., Pufall, M. A., Krishnan, S., Duda, K., Cohen, M. S., Maglathlin, R. L., McFarland, J. M., Miller, R. M., Frödin, M., & Taunton, J. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.925 · Cited by 493
Modification of histidine residues in proteins by reaction with 4-hydroxynonenal.
Uchida, K., & Stadtman, E. R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4544 · Cited by 491
Global profiling of lysine reactivity and ligandability in the human proteome
Hacker, S. M., Backus, K. M., Lazear, M. R., Forli, S., Correia, B. E., & Cravatt, B. F. (2017) · Nature Chemistry · doi:10.1038/nchem.2826 · Cited by 485
Nagy, P. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4973 · Cited by 477
A Perfluoroaryl-Cysteine S N Ar Chemistry Approach to Unprotected Peptide Stapling
Spokoyny, A. M., Zou, Y., Ling, J. J., Yu, H., Lin, Y.-S., & Pentelute, B. L. (2013) · Journal of the American Chemical Society · doi:10.1021/ja400119t · Cited by 474
Large shifts in pK a values of lysine residues buried inside a protein
Isom, D. G., Castañeda, C. A., Cannon, B. R., & García-Moreno E., B. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010750108 · Cited by 466
Site-directed ligand discovery
Erlanson, D. A., Braisted, A. C., Raphael, D. R., Randal, M., Stroud, R. M., Gordon, E. M., & Wells, J. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9367 · Cited by 466
Nucleophilic reactivity constants toward methyl iodide and trans-dichlorodi(pyridine)platinum(II)
Pearson, R. G., Sobel, H. R., & Songstad, J. (1968) · Journal of the American Chemical Society · doi:10.1021/ja01004a021 · Cited by 455
Structure of Human Methionine Aminopeptidase-2 Complexed with Fumagillin
Liu, S., Widom, J., Kemp, C. W., Crews, C. M., & Clardy, J. (1998) · Science · doi:10.1126/science.282.5392.1324 · Cited by 440
The Metabolic Serine Hydrolases and Their Functions in Mammalian Physiology and Disease
Long, J. Z., & Cravatt, B. F. (2011) · Chemical Reviews · doi:10.1021/cr200075y · Cited by 425
Prolonged and tunable residence time using reversible covalent kinase inhibitors
Bradshaw, J. M., McFarland, J. M., Paavilainen, V. O., Bisconte, A., Tam, D., Phan, V. T., Romanov, S., Finkle, D., Shu, J., Patel, V., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1817 · Cited by 422
Chemical Protein Modification through Cysteine
Gunnoo, S. B., & Madder, A. (2016) · ChemBioChem · doi:10.1002/cbic.201500667 · Cited by 407
Protein Chemical Modification on Endogenous Amino Acids
Baslé, E., Joubert, N., & Pucheault, M. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.02.008 · Cited by 406
A Perspective on the Kinetics of Covalent and Irreversible Inhibition
Strelow, J. M. (2017) · SLAS Discovery · doi:10.1177/1087057116671509 · Cited by 392
Chemical proteomics approaches for identifying the cellular targets of natural products
Wright, M. H., & Sieber, S. A. (2016) · Natural Product Reports · doi:10.1039/c6np00001k · Cited by 391
Broad-Spectrum Kinase Profiling in Live Cells with Lysine-Targeted Sulfonyl Fluoride Probes
Zhao, Q., Ouyang, X., Wan, X., Gajiwala, K. S., Kath, J. C., Jones, L. H., Burlingame, A. L., & Taunton, J. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.6b08536 · Cited by 388
Strain-Release Heteroatom Functionalization: Development, Scope, and Stereospecificity
Lopchuk, J. M., Fjelbye, K., Kawamata, Y., Malins, L. R., Pan, C., Gianatassio, R., Wang, J., Prieto, L., Bradow, J., Brandt, T. A., et al. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.6b13229 · Cited by 381
Application of the Theory of Diffusion-controlled Reactions to Enzyme Kinetics
Alberty, R. A., & Hammes, G. G. (1958) · The Journal of Physical Chemistry · doi:10.1021/j150560a005 · Cited by 360
A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors
Lanning, B. R., Whitby, L. R., Dix, M. M., Douhan, J., Gilbert, A. M., Hett, E. C., Johnson, T. O., Joslyn, C., Kath, J. C., Niessen, S., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1582 · Cited by 359
In Situ Kinase Profiling Reveals Functionally Relevant Properties of Native Kinases
Patricelli, M. P., Nomanbhoy, T. K., Wu, J., Brown, H., Zhou, D., Zhang, J., Jagannathan, S., Aban, A., Okerberg, E., Herring, C., et al. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.04.011 · Cited by 348
A Three-Component Mannich-Type Reaction for Selective Tyrosine Bioconjugation
Joshi, N. S., Whitaker, L. R., & Francis, M. B. (2004) · Journal of the American Chemical Society · doi:10.1021/ja0439017 · Cited by 348
On Terminal Alkynes That Can React with Active-Site Cysteine Nucleophiles in Proteases
Ekkebus, R., van Kasteren, S. I., Kulathu, Y., Scholten, A., Berlin, I., Geurink, P. P., de Jong, A., Goerdayal, S., Neefjes, J., Heck, A. J. R., et al. (2013) · Journal of the American Chemical Society · doi:10.1021/ja309802n · Cited by 347
Structure-based design of targeted covalent inhibitors
Lonsdale, R., & Ward, R. A. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00220c · Cited by 344
Tyrosine Bioconjugation through Aqueous Ene-Type Reactions: A Click-Like Reaction for Tyrosine
Ban, H., Gavrilyuk, J., & Barbas, C. F. (2010) · Journal of the American Chemical Society · doi:10.1021/ja909062q · Cited by 343
Youdim, M. B. H., Gross, A., & Finberg, J. P. M. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703826 · Cited by 342
Unconventional serine proteases: Variations on the catalytic Ser/His/Asp triad configuration
Ekici, Ö. D., Paetzel, M., & Dalbey, R. E. (2008) · Protein Science · doi:10.1110/ps.035436.108 · Cited by 334
Inactivation of the protease inhibitor phenylmethylsulfonyl fluoride in buffers
James, G. T. (1978) · Analytical Biochemistry · doi:10.1016/0003-2697(78)90784-4 · Cited by 328
Structure of mitochondrial aldehyde dehydrogenase: the genetic component of ethanol aversion
Steinmetz, C. G., Xie, P., Weiner, H., & Hurley, T. D. (1997) · Structure · doi:10.1016/s0969-2126(97)00224-4 · Cited by 324
Flanagan, M. E., Abramite, J. A., Anderson, D. P., Aulabaugh, A., Dahal, U. P., Gilbert, A. M., Li, C., Montgomery, J., Oppenheimer, S. R., Ryder, T., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501412a · Cited by 320
Covalent inhibitors design and discovery.
De Cesco, S., Kurian, J., Dufresne, C., Mittermaier, A. K., & Moitessier, N. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.06.019 · Cited by 315
The pharmacological landscape and therapeutic potential of serine hydrolases
Bachovchin, D. A., & Cravatt, B. F. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3620 · Cited by 308
Idiosyncratic Drug Reactions: Current Understanding
Uetrecht, J. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105150 · Cited by 304
Formation and signaling actions of electrophilic lipids
Schopfer, F. J., Cipollina, C., & Freeman, B. A. (2011) · Chemical Reviews · doi:10.1021/cr200131e · Cited by 299
Preventing Thiol-Yne Addition Improves the Specificity of Strain-Promoted Azide–Alkyne Cycloaddition
van Geel, R., Pruijn, G. J. M., van Delft, F. L., & Boelens, W. C. (2012) · Bioconjugate Chemistry · doi:10.1021/bc200365k · Cited by 298
DNA damage and mutagenesis induced by nitrogen mustards
Povirk, L. F., & Shuker, D. E. (1994) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/0165-1110(94)90015-9 · Cited by 297
Mortenson, D. E., Brighty, G. J., Plate, L., Bare, G., Chen, W., Li, S., Wang, H., Cravatt, B. F., Forli, S., Powers, E. T., et al. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.7b08366 · Cited by 292
Mendgen, T., Steuer, C., & Klein, C. D. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201243p · Cited by 290
Concerted nucleophilic aromatic substitutions
Kwan, E. E., Zeng, Y., Besser, H. A., & Jacobsen, E. N. (2018) · Nature Chemistry · doi:10.1038/s41557-018-0079-7 · Cited by 287
Chen, W., Dong, J., Plate, L., Mortenson, D. E., Brighty, G. J., Li, S., Liu, Y., Galmozzi, A., Lee, P. S., Hulce, J. J., et al. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b02960 · Cited by 286
Schwartz, P. A., Kuzmic, P., Solowiej, J., Bergqvist, S., Bolanos, B., Almaden, C., Nagata, A., Ryan, K., Feng, J., Dalvie, D., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313733111 · Cited by 281
Iminoboronates: A New Strategy for Reversible Protein Modification
Cal, P. M. S. D., Vicente, J. B., Pires, E., Coelho, A. V., Veiros, L. F., Cordeiro, C., & Gois, P. M. P. (2012) · Journal of the American Chemical Society · doi:10.1021/ja303436y · Cited by 275
Structure of the Adenosine A1 Receptor Reveals the Basis for Subtype Selectivity
Glukhova, A., Thal, D. M., Nguyen, A. T., Vecchio, E. A., Jörg, M., Scammells, P. J., May, L. T., Sexton, P. M., & Christopoulos, A. (2017) · Cell · doi:10.1016/j.cell.2017.01.042 · Cited by 275
Tsou, H.-R., Mamuya, N., Johnson, B. D., Reich, M. F., Gruber, B. C., Ye, F., Nilakantan, R., Shen, R., Discafani, C., DeBlanc, R., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0005555 · Cited by 271
Perspectives on Structure and Mechanism in Organic Chemistry
Carroll, F. A. (1997) · Cited by 270
Smaill, J. B., Rewcastle, G. W., Loo, J. A., Greis, K. D., Chan, O. H., Reyner, E. L., Lipka, E., Showalter, H. D. H., Vincent, P. W., Elliott, W. L., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990482t · Cited by 269
Wissner, A., Overbeek, E., Reich, M. F., Floyd, M. B., Johnson, B. D., Mamuya, N., Rosfjord, E. C., Discafani, C., Davis, R., Shi, X., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020241c · Cited by 264
Krishnan, S., Miller, R. M., Tian, B., Mullins, R. D., Jacobson, M. P., & Taunton, J. (2014) · Journal of the American Chemical Society · doi:10.1021/ja505194w · Cited by 260
Chemical methods for mapping cysteine oxidation
Alcock, L. J., Perkins, M. V., & Chalker, J. M. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00607a · Cited by 251
Siklos, M., BenAissa, M., & Thatcher, G. R. J. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.08.001 · Cited by 249
Disparate proteome reactivity profiles of carbon electrophiles
Weerapana, E., Simon, G. M., & Cravatt, B. F. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.91 · Cited by 246
Wang, N., Yang, B., Fu, C., Zhu, H., Zheng, F., Kobayashi, T., Liu, J., Li, S., Ma, C., Wang, P. G., et al. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b01087 · Cited by 245
Tamura, T., Ueda, T., Goto, T., Tsukidate, T., Shapira, Y., Nishikawa, Y., Fujisawa, A., & Hamachi, I. (2018) · Nature Communications · doi:10.1038/s41467-018-04343-0 · Cited by 242
Thiol/disulfide redox states in signaling and sensing
Go, Y.-M., & Jones, D. P. (2013) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.764840 · Cited by 241
Lysine‐Targeting Covalent Inhibitors
Pettinger, J., Jones, K., & Cheeseman, M. D. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201707630 · Cited by 236
Platzer, G., Okon, M., & McIntosh, L. P. (2014) · Journal of Biomolecular NMR · doi:10.1007/s10858-014-9862-y · Cited by 231
Target discovery in small-molecule cell-based screens by in situ proteome reactivity profiling
Evans, M. J., Saghatelian, A., Sorensen, E. J., & Cravatt, B. F. (2005) · Nature Biotechnology · doi:10.1038/nbt1149 · Cited by 230
Covalent protein modification: the current landscape of residue-specific electrophiles
Shannon, D. A., & Weerapana, E. (2015) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2014.10.021 · Cited by 230
Huth, J. R., Mendoza, R., Olejniczak, E. T., Johnson, R. W., Cothron, D. A., Liu, Y., Lerner, C. G., Chen, J., & Hajduk, P. J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0455547 · Cited by 228
Glutathione conjugation as a bioactivation reaction
van Bladeren, P. J. (2000) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(00)00214-3 · Cited by 226
The Cysteinome of Protein Kinases as a Target in Drug Development
Chaikuad, A., Koch, P., Laufer, S. A., & Knapp, S. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201707875 · Cited by 225
Self-citationTransition Metal-Free Tryptophan-Selective Bioconjugation of Proteins
Seki, Y., Ishiyama, T., Sasaki, D., Abe, J., Sohma, Y., Oisaki, K., & Kanai, M. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b06692 · Cited by 217
Phenethyl isothiocyanate: A comprehensive review of anti-cancer mechanisms
Gupta, P., Wright, S. E., Kim, S.-H., & Srivastava, S. K. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.08.003 · Cited by 209
Esch, F. S., & Allison, W. S. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34585-4 · Cited by 207
Inhibition of Mcl-1 through covalent modification of a noncatalytic lysine side chain
Akçay, G., Belmonte, M. A., Aquila, B., Chuaqui, C., Hird, A. W., Lamb, M. L., Rawlins, P. B., Su, N., Tentarelli, S., Grimster, N. P., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2174 · Cited by 207
Diverse Functional Roles of Reactive Cysteines
Pace, N. J., & Weerapana, E. (2013) · ACS Chemical Biology · doi:10.1021/cb3005269 · Cited by 204
Li, Z., Qian, L., Li, L., Bernhammer, J. C., Huynh, H. V., Lee, J., & Yao, S. Q. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201508104 · Cited by 202
Toda, N., Asano, S., & Barbas, C. F. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201306241 · Cited by 200
Ban, H., Nagano, M., Gavrilyuk, J., Hakamata, W., Inokuma, T., & Barbas, C. F. (2013) · Bioconjugate Chemistry · doi:10.1021/bc300665t · Cited by 200
Covalent Binding to Tubulin by Isothiocyanates
Mi, L., Xiao, Z., Hood, B. L., Dakshanamurthy, S., Wang, X., Govind, S., Conrads, T. P., Veenstra, T. D., & Chung, F.-L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802330200 · Cited by 199
Redox Regulation of Epidermal Growth Factor Receptor Signaling through Cysteine Oxidation
Truong, T. H., & Carroll, K. S. (2012) · Biochemistry · doi:10.1021/bi301441e · Cited by 196
Chemical proteomic map of dimethyl fumarate–sensitive cysteines in primary human T cells
Blewett, M. M., Xie, J., Zaro, B. W., Backus, K. M., Altman, A., Teijaro, J. R., & Cravatt, B. F. (2016) · Science Signaling · doi:10.1126/scisignal.aaf7694 · Cited by 194
Brown, S. P., & Smith, A. B. (2015) · Journal of the American Chemical Society · doi:10.1021/ja512880g · Cited by 194
Progress with covalent small-molecule kinase inhibitors
Zhao, Z., & Bourne, P. E. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.035 · Cited by 194
Covalent inhibitors of glycosidases and their applications in biochemistry and biology
Rempel, B. P., & Withers, S. G. (2008) · Glycobiology · doi:10.1093/glycob/cwn041 · Cited by 193
Bender, A. T., Gardberg, A., Pereira, A., Johnson, T., Wu, Y., Grenningloh, R., Head, J., Morandi, F., Haselmayer, P., & Liu-Bujalski, L. (2017) · Molecular Pharmacology · doi:10.1124/mol.116.107037 · Cited by 193
Kim, D. H., Lees, W. J., Kempsell, K. E., Lane, W. S., Duncan, K., & Walsh, C. T. (1996) · Biochemistry · doi:10.1021/bi952937w · Cited by 192
Electrophilic Fragment-Based Design of Reversible Covalent Kinase Inhibitors
Miller, R. M., Paavilainen, V. O., Krishnan, S., Serafimova, I. M., & Taunton, J. (2013) · Journal of the American Chemical Society · doi:10.1021/ja401221b · Cited by 191
Expanding the Armory: Predicting and Tuning Covalent Warhead Reactivity
Lonsdale, R., Burgess, J., Colclough, N., Davies, N. L., Lenz, E. M., Orton, A. L., & Ward, R. A. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00553 · Cited by 190
Rational Targeting of Active-Site Tyrosine Residues Using Sulfonyl Fluoride Probes
Hett, E. C., Xu, H., Geoghegan, K. F., Gopalsamy, A., Kyne, R. E., Menard, C. A., Narayanan, A., Parikh, M. D., Liu, S., Roberts, L., et al. (2015) · ACS Chemical Biology · doi:10.1021/cb5009475 · Cited by 190
Woodward, R. B., Olofson, R. A., & Mayer, H. (1961) · Journal of the American Chemical Society · doi:10.1021/ja01465a072 · Cited by 189
Bioactivation and Hepatotoxicity of Nitroaromatic Drugs
Boelsterli, U., Ho, H., Zhou, S., & Yeow Leow, K. (2006) · Current Drug Metabolism · doi:10.2174/138920006778520606 · Cited by 186
Identification of Novel p38α MAP Kinase Inhibitors Using Fragment-Based Lead Generation
Gill, A. L., Frederickson, M., Cleasby, A., Woodhead, S. J., Carr, M. G., Woodhead, A. J., Walker, M. T., Congreve, M. S., Devine, L. A., Tisi, D., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049575n · Cited by 186
Grimster, N. P., Connelly, S., Baranczak, A., Dong, J., Krasnova, L. B., Sharpless, K. B., Powers, E. T., Wilson, I. A., & Kelly, J. W. (2013) · Journal of the American Chemical Society · doi:10.1021/ja311729d · Cited by 186
Babaoglu, K., Simeonov, A., Irwin, J. J., Nelson, M. E., Feng, B., Thomas, C. J., Cancian, L., Costi, M. P., Maltby, D. A., Jadhav, A., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701500e · Cited by 178
Understanding the Functional Roles of Amino Acid Residues in Enzyme Catalysis
Holliday, G. L., Mitchell, J. B. O., & Thornton, J. M. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.05.015 · Cited by 175
Reversible Cysteine Oxidation in Hydrogen Peroxide Sensing and Signal Transduction
García-Santamarina, S., Boronat, S., & Hidalgo, E. (2014) · Biochemistry · doi:10.1021/bi401700f · Cited by 174
Keap Calm, and Carry on Covalently
Wilson, A. J., Kerns, J. K., Callahan, J. F., & Moody, C. J. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400224q · Cited by 171
A Fragment-Based Method to Discover Irreversible Covalent Inhibitors of Cysteine Proteases
Kathman, S. G., Xu, Z., & Statsyuk, A. V. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500345q · Cited by 170
Mukherjee, H., Debreczeni, J., Breed, J., Tentarelli, S., Aquila, B., Dowling, J. E., Whitty, A., & Grimster, N. P. (2017) · Organic & Biomolecular Chemistry · doi:10.1039/c7ob02028g · Cited by 167
Jones, M. W., Mantovani, G., Blindauer, C. A., Ryan, S. M., Wang, X., Brayden, D. J., & Haddleton, D. M. (2012) · Journal of the American Chemical Society · doi:10.1021/ja211855q · Cited by 165
Crystal Structure of the Human 20S Proteasome in Complex with Carfilzomib
Harshbarger, W., Miller, C., Diedrich, C., & Sacchettini, J. (2015) · Structure · doi:10.1016/j.str.2014.11.017 · Cited by 164
Dacomitinib: First Global Approval
Shirley, M. (2018) · Drugs · doi:10.1007/s40265-018-1028-x · Cited by 163
Jöst, C., Nitsche, C., Scholz, T., Roux, L., & Klein, C. D. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5006918 · Cited by 162
Sulfonyl Fluorides (SFs): More Than Click Reagents?
Chinthakindi, P. K., & Arvidsson, P. I. (2018) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201800464 · Cited by 162
Krenske, E. H., Petter, R. C., & Houk, K. N. (2016) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.6b02188 · Cited by 158
A clickable inhibitor reveals context-dependent autoactivation of p90 RSK
Cohen, M. S., Hadjivassiliou, H., & Taunton, J. (2007) · Nature Chemical Biology · doi:10.1038/nchembio859 · Cited by 156
Oballa, R. M., Truchon, J., Bayly, C. I., Chauret, N., Day, S., Crane, S. N., & Berthelette, C. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.11.044 · Cited by 150
Sanches, M., Duffy, N. M., Talukdar, M., Thevakumaran, N., Chiovitti, D., Canny, M. D., Lee, K. P. K., Kurinov, I. V., Uehling, D., Al‐awar, R., et al. (2014) · Nature Communications · doi:10.1038/ncomms5202 · Cited by 150
Scheers, E. M., Leclercq, L., de Jong, J., Bode, N., Bockx, M., Laenen, A., Cuyckens, F., Skee, D. M., Murphy, J., Sukbuntherng, J., et al. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.060061 · Cited by 148
Investigating the Proteome Reactivity and Selectivity of Aryl Halides
Shannon, D. A., Banerjee, R., Webster, E. R., Bak, D. W., Wang, C., & Weerapana, E. (2014) · Journal of the American Chemical Society · doi:10.1021/ja4116204 · Cited by 146
Covalent Enzyme Inhibition through Fluorosulfate Modification of a Noncatalytic Serine Residue
Fadeyi, O., Hoth, L. R., Choi, C., Feng, X., Gopalsamy, A., Hett, E. C., Kyne, R. E., Robinson, R. P., & Jones, L. H. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00403 · Cited by 146
Grishin, N. V., Osterman, A. L., Brooks, H. B., Phillips, M. A., & Goldsmith, E. J. (1999) · Biochemistry · doi:10.1021/bi9915115 · Cited by 145
Sample Preparation for Peptide Mapping— A Pharmaceutical Quality-Control Perspective
Lundell, N., & Schreitmüller, T. (1999) · Analytical Biochemistry · doi:10.1006/abio.1998.2919 · Cited by 145
Hatcher, J. M., Wu, G., Zeng, C., Zhu, J., Fan, M., Patel, S. H., Wang, W., Ficarro, S. B., Leggett, A. L., Powell, C. E., et al. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.01.013 · Cited by 145
Targeting biomolecules with reversible covalent chemistry
Bandyopadhyay, A., & Gao, J. (2016) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2016.08.011 · Cited by 143
Biological targets of isothiocyanates
Brown, K., & Hampton, M. B. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.06.004 · Cited by 143
Larraufie, M., Yang, W. S., Jiang, E., Thomas, A. G., Slusher, B. S., & Stockwell, B. R. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.07.018 · Cited by 142
Eschenburg, S., Priestman, M. A., & Schönbrunn, E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411325200 · Cited by 141
Dalton, S. E., Dittus, L., Thomas, D. A., Convery, M. A., Nunes, J., Bush, J. T., Evans, J. P., Werner, T., Bantscheff, M., Murphy, J. A., et al. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b08979 · Cited by 141
Covalent inhibitors: an opportunity for rational target selectivity
Lagoutte, R., Patouret, R., & Winssinger, N. (2017) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2017.05.008 · Cited by 138
The Proteasome in Modern Drug Discovery: Second Life of a Highly Valuable Drug Target
Cromm, P. M., & Crews, C. M. (2017) · ACS Central Science · doi:10.1021/acscentsci.7b00252 · Cited by 136
Fighting cancer drug resistance: Opportunities and challenges for mutation-specific EGFR inhibitors
Juchum, M., Günther, M., & Laufer, S. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.05.002 · Cited by 134
Self-citationIdentification and Characterization of an Irreversible Inhibitor of CDK2
Anscombe, E., Meschini, E., Mora-Vidal, R., Martin, M. P., Staunton, D., Geitmann, M., Danielson, U. H., Stanley, W. A., Wang, L.-Z., Reuillon, T. D., et al. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2015.07.018 · Cited by 134
Determining Cysteines Available for Covalent Inhibition Across the Human Kinome
Zhao, Z., Liu, Q., Bliven, S. E., Xie, L., & Bourne, P. E. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01815 · Cited by 134
Gupta, V., & Carroll, K. S. (2015) · Chemical Science · doi:10.1039/c5sc02569a · Cited by 132
Diverse Redoxome Reactivity Profiles of Carbon Nucleophiles
Gupta, V., Yang, J. H., Liebler, D. C., & Carroll, K. S. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b01791 · Cited by 132
SAR and Mode of Action of Novel Non-Nucleoside Inhibitors of Hepatitis C NS5b RNA Polymerase
Powers, J. P., Piper, D. E., Li, Y., Mayorga, V., Anzola, J. V., Chen, J., Jaén, J. C., Lee, G., Liu, J., Peterson, M. G., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050859x · Cited by 131
Strained Cycloalkynes as New Protein Sulfenic Acid Traps
Poole, T. H., Reisz, J. A., Zhao, W., Poole, L. B., Furdui, C. M., & King, S. B. (2014) · Journal of the American Chemical Society · doi:10.1021/ja500364r · Cited by 130
Novel, Nonpeptidic Cyanamides as Potent and Reversible Inhibitors of Human Cathepsins K and L
Falgueyret, J., Oballa, R. M., Okamoto, O., Wesolowski, G. A., Aubin, Y., Rydzewski, R. M., Prasit, P., Riendeau, D., Rodan, S. B., & Percival, M. D. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm0003440 · Cited by 129
Sommer, S., Weikart, N. D., Linne, U., & Mootz, H. D. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.02.039 · Cited by 127
Forster, M., Chaikuad, A., Bauer, S. M., Holstein, J., Robers, M. B., Corona, C. R., Gehringer, M., Pfaffenrot, E., Ghoreschi, K., Knapp, S., et al. (2016) · Cell Chemical Biology · doi:10.1016/j.chembiol.2016.10.008 · Cited by 126
Self-citationMethylsulfonyl Benzothiazole (MSBT): A Selective Protein Thiol Blocking Reagent
Zhang, D., Devarie‐Baez, N. O., Li, Q., Lancaster, J. R., & Xian, M. (2012) · Organic Letters · doi:10.1021/ol301370s · Cited by 123
Evaluation of Methods for the Calculation of the p K a of Cysteine Residues in Proteins
Awoonor‐Williams, E., & Rowley, C. N. (2016) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.6b00631 · Cited by 123
Shiu, H., Chan, T. H., Ho, C., Liu, Y., Wong, M., & Che, C. (2009) · Chemistry - A European Journal · doi:10.1002/chem.200800669 · Cited by 121
Targeting bacteria via iminoboronate chemistry of amine-presenting lipids
Bandyopadhyay, A., McCarthy, K. A., Kelly, M. A., & Gao, J. (2015) · Nature Communications · doi:10.1038/ncomms7561 · Cited by 119
Allenamides as Orthogonal Handles for Selective Modification of Cysteine in Peptides and Proteins
Abbas, A., Xing, B., & Loh, T. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403121 · Cited by 117
Mechanistic Insights into a Classic Wonder Drug─Aspirin
Lei, J., Zhou, Y., Xie, D., & Zhang, Y. (2014) · Journal of the American Chemical Society · doi:10.1021/ja5112964 · Cited by 116
A Suite of Activity-Based Probes for Human Cytochrome P450 Enzymes
Wright, A., Song, J. D., & Cravatt, B. F. (2009) · Journal of the American Chemical Society · doi:10.1021/ja9037609 · Cited by 115
Wood, E. R., Shewchuk, L. M., Ellis, B., Brignola, P. S., Brashear, R. L., Caferro, T. R., Dickerson, S. H., Dickson, H. D., Donaldson, K. H., Gaul, M. D., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708281105 · Cited by 113
Shibata, Y., & Chiba, M. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.061424 · Cited by 111
Baranczak, A., Liu, Y., Connelly, S., Han, W., Greiner, E. R., Genereux, J. C., Wiseman, R. L., Eisele, Y. S., Bradbury, N. C., Dong, J., et al. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b03042 · Cited by 109
Günther, M., Juchum, M., Kelter, G., Fiebig, H. H., & Laufer, S. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201603736 · Cited by 108
Self-citationCaraballo, R., Dong, H., Ribeiro, J. P., Jiménez‐Barbero, J., & Ramström, O. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200903920 · Cited by 106
L-764406 Is a Partial Agonist of Human Peroxisome Proliferator-activated Receptor γ
Elbrecht, A., Chen, Y., Adams, A., Berger, J. P., Griffin, P. R., Klatt, T., Zhang, B., Menke, J. G., Zhou, G., Smith, R. G., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7913 · Cited by 105
Tung, C. L., Wong, C. T. T., Fung, Y. M. E., & Li, X. (2016) · Organic Letters · doi:10.1021/acs.orglett.6b00983 · Cited by 105
Nakamura, T., Kawai, Y., Kitamoto, N., Osawa, T., & Kato, Y. (2009) · Chemical Research in Toxicology · doi:10.1021/tx8003906 · Cited by 103
Chemical Proteomic Probes for Profiling Cytochrome P450 Activities and Drug Interactions In Vivo
Wright, A., & Cravatt, B. F. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.08.008 · Cited by 103
Covalent Protein Labeling at Glutamic Acids
Martín‐Gago, P., Fansa, E. K., Winzker, M., Murarka, S., Janning, P., Schultz‐Fademrecht, C., Baumann, M., Wittinghofer, A., & Waldmann, H. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.03.015 · Cited by 103
Gu, C., Shannon, D. A., Colby, T., Wang, Z., Shabab, M., Selva, K., Villamor, J. G., McLaughlin, C. J., Weerapana, E., Kaiser, M., et al. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.01.016 · Cited by 102
Affinity Profiling of the Cellular Kinome for the Nucleotide Cofactors ATP, ADP, and GTP
Becher, I., Savitski, M. M., Savitski, M. F., Hopf, C., Bantscheff, M., & Drewes, G. (2012) · ACS Chemical Biology · doi:10.1021/cb3005879 · Cited by 100
Improving the Serum Stability of Site-Specific Antibody Conjugates with Sulfone Linkers
Patterson, J. T., Asano, S., Li, X., Rader, C. M., & Barbas, C. F. (2014) · Bioconjugate Chemistry · doi:10.1021/bc500276m · Cited by 99
Martín‐Gago, P., Fansa, E. K., Klein, C. H., Murarka, S., Janning, P., Schürmann, M., Metz, M., Ismail, S., Schultz‐Fademrecht, C., Baumann, M., et al. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201610957 · Cited by 99
Proteome-wide Map of Targets of T790M-EGFR-Directed Covalent Inhibitors
Niessen, S., Dix, M. M., Barbas, S., Potter, Z. E., Lu, S., Brodsky, O., Planken, S., Behenna, D. C., Almaden, C., Gajiwala, K. S., et al. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.08.017 · Cited by 99
Ibrutinib: A Review in Chronic Lymphocytic Leukaemia
Deeks, E. D. (2017) · Drugs · doi:10.1007/s40265-017-0695-3 · Cited by 98
Expanding the scope of electrophiles capable of targeting K-Ras oncogenes
McGregor, L. M., Jenkins, M. L., Kerwin, C., Burke, J. E., & Shokat, K. M. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b00271 · Cited by 97
Federici, L., Sterzo, C. L., Pezzola, S., Matteo, A. D., Scaloni, F., Federici, G., & Caccuri, A. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1314 · Cited by 95
Protein cysteine oxidation in redox signaling: Caveats on sulfenic acid detection and quantification
Forman, H. J., Davies, M. J., Krämer, A. C., Miotto, G., Zaccarin, M., Zhang, H., & Ursini, F. (2016) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2016.09.013 · Cited by 93
Optimized Diazo Scaffold for Protein Esterification
Mix, K. A., & Raines, R. T. (2015) · Organic Letters · doi:10.1021/acs.orglett.5b00840 · Cited by 91
Liu, Y., Xie, Z., Zhao, D., Zhu, J., Mao, F., Tang, S., Xu, H., Luo, C., Geng, M., Huang, M., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01245 · Cited by 90
Carbonyl reduction pathways in drug metabolism
Malátková, P., & Wsól, V. (2013) · Drug Metabolism Reviews · doi:10.3109/03602532.2013.853078 · Cited by 88
Identification of Cyanamide-Based Janus Kinase 3 (JAK3) Covalent Inhibitors
Casimiro‐Garcia, A., Trujillo, J. I., Vajdos, F. F., Juba, B. M., Banker, M. E., AULABAUGH, A. E., Balbo, P., Bauman, J. N., Chrencik, J., Coe, J. W., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01308 · Cited by 87
Cited by
RAS-targeted therapies: is the undruggable drugged?
Moore, A. R., Rosenberg, S. C., McCormick, F., & Malek, S. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0068-6 · Cited by 1,103
Spirocyclic Scaffolds in Medicinal Chemistry
Hiesinger, K., Dar’in, D., Proschak, E., & Krasavin, M. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01473 · Cited by 618
PROTACs: An Emerging Therapeutic Modality in Precision Medicine
Nalawansha, D. A., & Crews, C. M. (2020) · Cell Chemical Biology · doi:10.1016/j.chembiol.2020.07.020 · Cited by 490
Ertl, P., Altmann, E., & McKenna, J. M. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00754 · Cited by 429
Covalent inhibitors: a rational approach to drug discovery
Sutanto, F., Konstantinidou, M., & Dömling, A. (2020) · RSC Medicinal Chemistry · doi:10.1039/d0md00154f · Cited by 389
Metadata
- Authors
- Gehringer, M., & Laufer, S. A.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-12-19
- Volume
- 62
- Issue
- 12
- Pages
- 5673-5724
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2904506792
- Cited by
- 714
- References
- 304
- FWCI
- 19.74
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.